BOCA RATON REGIONAL HOSPITAL EARNS NATIONAL RESEARCH CORPORATION’S CONSUMER CHOICE AWARD FOR SECOND YEAR IN A ROW

BOCA RATON, FL – November 28, 2016 – RELEASE PDF Boca Raton Regional Hospital has been named a 2016/2017 Consumer Choice Award recipient by National Research Corporation (NRC). The annual accolade identifies hospitals across the United States that healthcare consumers choose as having the highest quality and image. Boca Regional again joins such prestigious institutions as Massachusetts General Hospital, Cleveland Clinic and The Johns Hopkins Hospital in this year’s listings, and is the sole provider in the Palm Beach County service area to receive the distinction.

MORE “BOCA RATON REGIONAL HOSPITAL EARNS NATIONAL RESEARCH CORPORATION’S CONSUMER CHOICE AWARD FOR SECOND YEAR IN A ROW”

LOCAL NEUROSURGEONS JOIN MARCUS NEUROSCIENCE INSTITUTE AT BOCA RATON REGIONAL HOSPITAL

Boca Raton Regional Hospital announces the appointments of Evan M. Packer, MD, and Lloyd Zucker, MD, to the Hospital’s Marcus Neuroscience Institute and BocaCare® physician network.

Dr. Packer is a board-certified neurosurgeon. He attended the University of South Florida Morsani College of Medicine in Tampa, Florida and performed his general surgery internship and neurological surgery residency at the University of South Florida Affiliated Hospitals and Clinics.

MORE “LOCAL NEUROSURGEONS JOIN MARCUS NEUROSCIENCE INSTITUTE AT BOCA RATON REGIONAL HOSPITAL”

BlinkBio Inc. Announces Exclusive Agreement with The Scripps Research Institute Providing Targeting Technology for Use in BlinkBio’s Tunable Drug Conjugates Platform

BlinkBio Inc., a biotechnology company advancing Tunable Drug Conjugates (TDCs) for cancer and other diseases, today announced the signing of an exclusive option agreement to license Dual Variable Domain-Fab (DVD-Fab) technology developed in the laboratories of Dr. Christoph Rader and Dr. William R. Roush at The Scripps Research Institute (TSRI) in Jupiter, FL. The technology comprises engineered antibody fragments that include regions of antibodies that recognize target proteins they are designed to bind, together with elements that allow the DVD-Fabs to connect to BlinkBio’s proprietary TDCs.

MORE “BlinkBio Inc. Announces Exclusive Agreement with The Scripps Research Institute Providing Targeting Technology for Use in BlinkBio’s Tunable Drug Conjugates Platform”

MDNA Life Sciences and University of Oxford to Collaborate to Develop a Mitochondrial Biomarker Blood-based Diagnostic for Endometriosis

WEST PALM BEACH, Florida, Nov. 1, 2016 /PRNewswire/ — MDNA Life Sciences Inc. (MDNA), a molecular diagnostics company specializing in the development of blood-based diagnostic tests based on the mitochondrial genome, announced today that it has entered into a collaboration agreement with the University of Oxford to further the development and validation of MDNA’s non-invasive blood-based test for endometriosis.

MORE “MDNA Life Sciences and University of Oxford to Collaborate to Develop a Mitochondrial Biomarker Blood-based Diagnostic for Endometriosis”

MEDICAL COMPLEX FEATURING WORLD-CLASS HOSPITAL TO LAUNCH IN WPB

Jupiter Medical Center and Mount Sinai Hospital of New York are expanding their alliance with an aggressive plan to bring a range of health care services to downtown West Palm Beach after a failed bid to do so last year. The Jupiter Medical Center Mount Sinai New York Plaza will be the new name for an office building at 625 N. Flagler Drive, formerly the Bank of America Centre.

MORE “MEDICAL COMPLEX FEATURING WORLD-CLASS HOSPITAL TO LAUNCH IN WPB”